Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells.

Zahaf, N-I; Lang, A E; Kaiser, L; Fichter, C D; Lassmann, S; McCluskey, A; Augspach, A; Aktories, K; Schmidt, G

Zahaf, N-I; Lang, A E; Kaiser, L; Fichter, C D; Lassmann, S; McCluskey, A; Augspach, A; Aktories, K; Schmidt, G.

Affiliation

Zahaf NI; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
Lang AE; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
Kaiser L; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
Fichter CD; Institute of Surgical Pathology, Medical Center - University of Freiburg, Breisacherstr. 115a, 79106 Freiburg, Germany.
Lassmann S; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
McCluskey A; Institute of Surgical Pathology, Medical Center - University of Freiburg, Breisacherstr. 115a, 79106 Freiburg, Germany.
Augspach A; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Aktories K; Comprehensive Cancer Center, Freiburg, Germany.
Schmidt G; BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiberg, Germany.

Sci Rep ; 7: 41252, 2017 01 27.

Article de En | MEDLINE | ID: mdl-28128281

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Toxines bactériennes / Tumeurs de l'oesophage / Carcinome épidermoïde / ADP ribose transferases / ADP-Ribosylation Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Sci Rep Année: 2017 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google